Status:
COMPLETED
Blood Pressure Control in African Americans
Lead Sponsor:
NYU Langone Health
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Cardiovascular Diseases
Hypertension
Eligibility:
All Genders
Phase:
NA
Brief Summary
The purpose of this study is to test the effectiveness of a multi-component evidence-based intervention that targets both patients and physicians, in improving BP control rates in patients followed in...
Detailed Description
BACKGROUND: African Americans (AA) have the highest prevalence of hypertension (HTN) in the U.S., with a resultant greater HTN-related mortality compared to whites. Barriers to BP Control in AA exist...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Uncontrolled Hypertension
- African American
Exclusion
Key Trial Info
Start Date :
September 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2010
Estimated Enrollment :
1039 Patients enrolled
Trial Details
Trial ID
NCT00233220
Start Date
September 1 2004
End Date
March 1 2010
Last Update
February 13 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU School of Medicine
New York, New York, United States, 10016